发明申请
US20120195905A1 TARGETED BINDING AGENTS DIRECTED TO DLL4 AND USES THEREOF 524
有权
针对DLL4的目标绑定代理及其用途524
- 专利标题： TARGETED BINDING AGENTS DIRECTED TO DLL4 AND USES THEREOF 524
- 专利标题（中）： 针对DLL4的目标绑定代理及其用途524
-
申请号： US13446637申请日： 2012-04-13
-
公开(公告)号： US20120195905A1公开(公告)日： 2012-08-02
- 发明人: Vahe Bedian , David Jenkins , Ian FOLTZ
- 申请人： Vahe Bedian , David Jenkins , Ian FOLTZ
- 申请人地址： US MD Gaithersburg
- 专利权人： Medlmmune, LLC
- 当前专利权人： Medlmmune, LLC
- 当前专利权人地址： US MD Gaithersburg
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/18 ; A61P35/00 ; C12N15/13
摘要：
The invention relates to targeted binding agents against DLL4 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to DLL4. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of DLL-4 and as diagnostics.
公开/授权文献
信息查询
